ARCpoint Inc. (ARC.V)
| Previous close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.1000 x N/A |
| Ask | 0.1100 x N/A |
| Day's range | 0.1000 - 0.1000 |
| 52-week range | 0.0800 - 0.2700 |
| Volume | |
| Avg. volume | 12,409 |
| Market cap | 10.21M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS
Greenville, South Carolina, May 23, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and direct to consumer (“DTC”) clinical lab testing services, announces that it will host a conference call at 11am Eastern time, Friday, May 24, 2024 to review the Company’s Q1 financial results for the period ending March 31, 2024. The dial-in number for the conference call is as follows: Canada /
- GlobeNewswire
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2023 Q4 AND FULL YEAR FINANCIAL RESULTS
Greenville, South Carolina, April 29, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and direct to consumer (“DTC”) clinical lab testing services, announces that it will host a conference call at 4pm Eastern time, Wednesday, May 1, 2024 to review the Company’s 2023 full year and fourth quarter, ending December 31, 2023 results. The dial-in number for the conference call is as foll
- GlobeNewswire
ARCPOINT ANNOUNCES CLOSING OF US$1.1 MILLION NON-BROKERED PRIVATE PLACEMENT
Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to announce that it has closed its previously announced non-brokered private placement (the “Offering”) for gross proceeds of US$1,100,000, through the sale of 11,000,000 Class A subordinate voting shares of the Company (each, a “Share”) at a price of US$0.10 per Share. The net proceeds from t
